Search research articles
Contact Us
Filters
Showing results (221-230 of 239) with videos related to
Page
of 24
Sort By:
Frontiers in Medicine
|
November 29, 2023
From numbers to medical knowledge: harnessing combinatorial data patterns to predict COVID-19 resource needs and distinguish patient subsets
Parthkumar H Satashia, Pablo Moreno Franco, Ariel L Rivas, et al.
Annals of the Rheumatic Diseases
|
September 24, 2025
Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular disease
Jon T Giles, Christina Charles-Schoeman, Maya H Buch, et al.
International Journal for Parasitology
|
October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy
Kayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
Journal of Comparative Pathology
|
March 31, 2018
Parotid Salivary Gland Basal Cell Adenocarcinoma in a Big-eared Opossum (Didelphis aurita)
J Díaz-Delgado, A A C Coimbra, C Dos Santos-Cirqueira, et al.
The Journal of Infectious Diseases
|
December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis
Deborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
Plos One
|
February 26, 2013
Feedback-based, system-level properties of vertebrate-microbial interactions
Ariel L Rivas, Mark D Jankowski, Renata Piccinini, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Antimicrobial Agents and Chemotherapy
|
July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase
Wesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
International Journal of Environmental Research and Public Health
|
August 10, 2019
Ecological and Epidemiological Findings Associated with Zoonotic Rabies Outbreaks and Control in Moshi, Tanzania, 2017-2018
Niwael Mtui-Malamsha, Raphael Sallu, Gladys R Mahiti, et al.
The Journal of Infectious Diseases
|
October 15, 2013
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation
Kayode K Ojo, Richard T Eastman, Ramasubbarao Vidadala, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 239) with videos related to
Sort By:
Page
of 24
Frontiers in Medicine
|
November 29, 2023
From numbers to medical knowledge: harnessing combinatorial data patterns to predict COVID-19 resource needs and distinguish patient subsets
Parthkumar H Satashia, Pablo Moreno Franco, Ariel L Rivas, et al.
Annals of the Rheumatic Diseases
|
September 24, 2025
Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular disease
Jon T Giles, Christina Charles-Schoeman, Maya H Buch, et al.
International Journal for Parasitology
|
October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy
Kayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
Journal of Comparative Pathology
|
March 31, 2018
Parotid Salivary Gland Basal Cell Adenocarcinoma in a Big-eared Opossum (Didelphis aurita)
J Díaz-Delgado, A A C Coimbra, C Dos Santos-Cirqueira, et al.
The Journal of Infectious Diseases
|
December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis
Deborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
Plos One
|
February 26, 2013
Feedback-based, system-level properties of vertebrate-microbial interactions
Ariel L Rivas, Mark D Jankowski, Renata Piccinini, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Antimicrobial Agents and Chemotherapy
|
July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase
Wesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
International Journal of Environmental Research and Public Health
|
August 10, 2019
Ecological and Epidemiological Findings Associated with Zoonotic Rabies Outbreaks and Control in Moshi, Tanzania, 2017-2018
Niwael Mtui-Malamsha, Raphael Sallu, Gladys R Mahiti, et al.
The Journal of Infectious Diseases
|
October 15, 2013
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation
Kayode K Ojo, Richard T Eastman, Ramasubbarao Vidadala, et al.
Page
of 24